Screener
Lexicon Pharmaceuticals LXRX Price / sales
Price / sales at other companies
Other financials
Where this comes from
Calculated from Lexicon Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Lexicon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001062822-26-000117
FAQ
- What is Lexicon Pharmaceuticals's price / sales?
- Lexicon Pharmaceuticals (LXRX) reported price / sales of 25.7× in Q2 2026.
- How has Lexicon Pharmaceuticals's price / sales changed year-over-year?
- Lexicon Pharmaceuticals's price / sales increased by 437.0% year-over-year, from 4.8× to 25.7×.
- What is the long-term trend for Lexicon Pharmaceuticals's price / sales?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's price / sales has grown at a -16.9% compound annual growth rate (CAGR), from 21.2× to 8.4×.
- What does price / sales mean?
- Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.
Ask your AI about Lexicon Pharmaceuticals's price / sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude